<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><!--The publisher of this article does not allow downloading of the full text in XML form.--><front><journal-meta><journal-id journal-id-type="nlm-ta">Drug Alcohol Depend</journal-id><journal-id journal-id-type="iso-abbrev">Drug Alcohol Depend</journal-id><journal-id journal-id-type="pmc-domain-id">319</journal-id><journal-id journal-id-type="pmc-domain">nihpa</journal-id><journal-title-group><journal-title>Drug and alcohol dependence</journal-title></journal-title-group><issn pub-type="ppub">0376-8716</issn><issn pub-type="epub">1879-0046</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>NIHPA Author Manuscripts</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC10655701</article-id><article-id pub-id-type="pmcid-ver">PMC10655701.319</article-id><article-id pub-id-type="pmcaid">10655701</article-id><article-id pub-id-type="pmcaiid">10655701</article-id><article-id pub-id-type="manuscript-id">NIHMS1937057</article-id><article-id pub-id-type="pmid">37688980</article-id><article-id pub-id-type="doi">10.1016/j.drugalcdep.2023.110946</article-id><article-id pub-id-type="manuscript-id-alternative">NIHMS1937057</article-id><article-id pub-id-type="manuscript-id-alternative">NIHPA1937057</article-id><article-version article-version-type="pmc-version">319</article-version><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Association between cannabis use disorder symptom severity and probability of clinically-documented diagnosis and treatment in a primary care sample</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Matson</surname><given-names initials="TE">Theresa E.</given-names></name><degrees>PhD, MPH</degrees><xref rid="A1" ref-type="aff">a</xref><xref rid="A2" ref-type="aff">b</xref><xref rid="A3" ref-type="aff">c</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Williams</surname><given-names initials="EC">Emily C.</given-names></name><degrees>PhD, MPH</degrees><xref rid="A1" ref-type="aff">a</xref><xref rid="A2" ref-type="aff">b</xref><xref rid="A3" ref-type="aff">c</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Lapham</surname><given-names initials="GT">Gwen T.</given-names></name><degrees>PhD, MPH, MSW</degrees><xref rid="A1" ref-type="aff">a</xref><xref rid="A2" ref-type="aff">b</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Oliver</surname><given-names initials="M">Malia</given-names></name><degrees>BA</degrees><xref rid="A1" ref-type="aff">a</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Hallgren</surname><given-names initials="KA">Kevin A.</given-names></name><degrees>PhD</degrees><xref rid="A1" ref-type="aff">a</xref><xref rid="A2" ref-type="aff">b</xref><xref rid="A4" ref-type="aff">d</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Bradley</surname><given-names initials="KA">Katharine A.</given-names></name><degrees>MD, MPH</degrees><xref rid="A1" ref-type="aff">a</xref><xref rid="A2" ref-type="aff">b</xref><xref rid="A5" ref-type="aff">e</xref></contrib></contrib-group><aff id="A1"><label>a</label>Kaiser Permanente Washington Health Research Institute, Seattle, WA, 98101, USA</aff><aff id="A2"><label>b</label>Department of Health Systems and Population Health, University of Washington School of Public Health, Seattle, WA 98195, USA</aff><aff id="A3"><label>c</label>Health Services Research &amp; Development (HSR&amp;D) Center for Innovation for Veteran-Centered and Value-Driven Care, Veterans Affairs (VA) Puget Sound Health Care System, Seattle, WA, 98101, USA</aff><aff id="A4"><label>d</label>Department of Psychiatry and Behavioral Sciences, University of Washington School of Medicine, Seattle, WA, 98195, USA</aff><aff id="A5"><label>e</label>Department of Medicine, University of Washington School of Medicine, Seattle, WA, 98195, USA</aff><author-notes><corresp id="CR1"><bold>Corresponding author:</bold> Theresa E. Matson (<email>tessa.e.matson@kp.org</email>), Address: 1730 Minor Ave., Suite 1600, Seattle, WA 98101; Phone: 253-720-1862</corresp></author-notes><pub-date pub-type="ppub"><day>01</day><month>10</month><year>2023</year></pub-date><pub-date pub-type="epub"><day>23</day><month>8</month><year>2023</year></pub-date><volume>251</volume><issue-id pub-id-type="pmc-issue-id">449309</issue-id><fpage>110946</fpage><lpage>110946</lpage><pub-history><event event-type="nihms-submitted"><date><day>20</day><month>10</month><year>2023</year></date></event><event event-type="pmc-release"><date><day>01</day><month>10</month><year>2024</year></date></event><event event-type="pmc-live"><date><day>01</day><month>10</month><year>2024</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-10-01 00:25:29.690"><day>01</day><month>10</month><year>2024</year></date></event></pub-history><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="nihms-1937057.pdf"/><abstract id="ABS1"><sec id="S1"><title>Background:</title><p id="P1">Brief cannabis screening followed by standardized assessment of symptoms may support diagnosis and treatment of cannabis use disorder (CUD). This study tested whether the probability of a medical provider diagnosing and treating CUD increased with the number of substance use disorder (SUD) symptoms documented in patients&#8217; EHRs.</p></sec><sec id="S2"><title>Methods:</title><p id="P2">This observational study used EHR and claims data from an integrated healthcare system. Adult patients were included who reported daily cannabis use and completed the Substance Use Symptom Checklist, a scaled measure of DSM-5 SUD symptoms (0&#8211;11), during routine care 3/1/2015&#8211;3/1/2021. Logistic regression estimated associations between SUD symptom counts and: 1) CUD diagnosis; 2) CUD treatment initiation; and 3) CUD treatment engagement, defined based on Healthcare Effectiveness Data and Information Set (HEDIS) ICD-codes and timelines. We tested moderation across age, gender, race, and ethnicity.</p></sec><sec id="S3"><title>Results:</title><p id="P3">Patients (N=13,947) were predominantly middle-age, male, White, and non-Hispanic. Among patients reporting daily cannabis use without other drug use (N=12,568), the probability of CUD diagnosis, treatment initiation, and engagement increased with each 1-unit increase in Symptom Checklist score (p&#8217;s&lt;0.001). However, probabilities of diagnosis, treatment, and engagement were low, even among those reporting &#8805;2 symptoms consistent with SUD: 14.0% diagnosed (95% CI: 11.7&#8211;21.6), 16.6% initiated treatment among diagnosed (11.7&#8211;21.6), and 24.3% engaged in treatment among initiated (15.8&#8211;32.7). Only gender moderated associations between Symptom Checklist and diagnosis (p=0.047) and treatment initiation (p=0.012). Findings were similar for patients reporting daily cannabis use with other drug use (N=1,379).</p></sec><sec id="S4"><title>Conclusion:</title><p id="P4">Despite documented symptoms, CUD was underdiagnosed and undertreated in medical settings.</p></sec></abstract><kwd-group><kwd>cannabis</kwd><kwd>cannabis use disorder</kwd><kwd>screening and assessment</kwd><kwd>diagnosis</kwd><kwd>treatment</kwd><kwd>primary care</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front></article></pmc-articleset>